Which is more profitable, AbbVie or CSL?

CSL keeps more of every sale as profit.

Which grows faster, AbbVie or CSL?

CSL grew its sales faster in recent years.

Which is cheaper, AbbVie or CSL?

CSL costs less for each unit of yearly profit (lower P/E).

Which has less debt, AbbVie or CSL?

CSL would need fewer years of earnings to pay off its debt.

AbbVieABBVvs

CSLCSL.AX

AbbVie vs CSL stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

CSL is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	AbbVie	CSL
	$521 billion	A$97.4 billion
	6.9%	19.5%
	+6.0%	+13.7%
	123.4×	22.0×
	3.5 years	1.8 years
	12.0%	9.3%
	3.1%	2.2%

Open AbbVie Open CSL

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: AbbVie vs Elevance Health · AbbVie vs Gilead Sciences · AbbVie vs GSK · AbbVie vs Intuitive Surgical · CSL vs Johnson & Johnson · CSL vs Eli Lilly · CSL vs Roche · CSL vs UnitedHealth